Chemoinformaics analysis of 1-METHYLQUINAZOLIN-4-ONE
| Molecular Weight | 160.176 | nRot | 0 |
| Heavy Atom Molecular Weight | 152.112 | nRig | 5 |
| Exact Molecular Weight | 160.064 | nRing | 2 |
| Solubility: LogS | -3.279 | nHRing | 1 |
| Solubility: LogP | 3.885 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 11 |
| nHA | 3 | APOL | 23.3663 |
| nHD | 0 | BPOL | 11.7437 |
| QED | 0.724 |
| Synth | 2.776 |
| Natural Product Likeliness | 0.759 |
| NR-PPAR-gamma | 0.019 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.006 |
| HIA | 0.004 |
| CACO-2 | -4.553 |
| MDCK | 0.0000291 |
| BBB | 0.613 |
| PPB | 0.977831 |
| VDSS | 3.03 |
| FU | 0.0383425 |
| CYP1A2-inh | 0.827 |
| CYP1A2-sub | 0.904 |
| CYP2c19-inh | 0.156 |
| CYP2c19-sub | 0.783 |
| CYP2c9-inh | 0.32 |
| CYP2c9-sub | 0.899 |
| CYP2d6-inh | 0.026 |
| CYP2d6-sub | 0.836 |
| CYP3a4-inh | 0.036 |
| CYP3a4-sub | 0.147 |
| CL | 10.959 |
| T12 | 0.647 |
| hERG | 0.004 |
| Ames | 0.015 |
| ROA | 0.106 |
| SkinSen | 0.54 |
| Carcinogencity | 0.164 |
| EI | 0.831 |
| Respiratory | 0.23 |
| NR-Aromatase | 0.844 |
| Antiviral | No |
| Prediction | 0.780665 |